DaVita Inc


DVA

Price

109.49


Change

0.03


High

111.63


Low

108.42


Avg Volume

566,395


PE Ratio

12.79


52 Week High

136.48


52 Week Low

94.38



Profile

DaVita Inc. provides kidney dialysis services through a network of 2,753 outpatient dialysis centers in the United States, serving 206,900 patients, and 259 outpatient dialysis centers in 10 other countries serving 28,700 patients. The company primarily treats end-stage renal disease , which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. In 2019, 69% of the company's revenues came from Medicare and other government-based health insurance programs. In 2019, 90% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 31% of revenues in 2019, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.